{"ModuleTitle": "Company Description", "CompanyName": "Akers Biosciences Inc.", "Symbol": "AKER", "Address": "201 GROVE RD, THOROFARE, New Jersey, 08086, United States of America", "Phone": "856-848-8698", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We were incorporated in 1989 in the state of New Jersey. Our principal executive\r\noffices are located at 201 Grove Road, Thorofare, New Jersey USA 08086 and our\r\ntelephone number is (856) 848-8698. Our corporate website address is\r\nwww.akersbio.com.\r\n\r\n \r\n\r\nOn March 23, 2020, we entered into a Membership Interest Purchase Agreement (the\r\n\"MIPA\") with the members of Cystron Biotech, LLC (individually, each a \"Seller,\"\r\nand collectively, the \"Sellers\"), pursuant to which the Company will acquire\r\n100% of the membership interests (the \"Membership Interests\") of Cystron\r\nBiotech, LLC (\"Cystron\"). Cystron is a party to license agreement with Premas\r\nBiotech PVT Ltd (\"Premas) whereby Premas granted Cystron, amongst other things,\r\nan exclusive license with respect to Premas' vaccine platform for the\r\ndevelopment of a vaccine against COVID-19 and other corona virus infections.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f25%2f0001493152-20-004650.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Howard R. Yeaton", "title": "Chief Executive Officer & Chief Financial Officer"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}